As baseball season begins, JAMA presents this double-header:
INSPIRE Pneumonia & INSPIRE UTI, a pair of transformative trials using CPOE prompts to create patient-specific MDRO risk estimates to reduce empiric extended-spectrum antibiotics #SHEASpring2024

This is our team. Truly amazing. We can transport patients around the world that in other facilities are too sick to get on the elevator.

Please share with interested docs. CFPRR is now taking nominations for the 2024 course. Deadline 2 Feb 2024.

Great opportunity at Houston Methodist to be part of a dynamic team! Adarsh Bhimraj

My first board meeting and the first IDSA Leadership Summit did not disappoint! I continue to be *awed* (impressed/amazed not strong enough adjectives) by colleagues on this team that somehow I am just now getting to know! Also not all the photos were this sedate 😂

Thanks Preeti Malani for a great conversation and I continue to be inspired by you and our amazing community!

Late breaking clinical trials #IDWeek2023

1. A Chikungunya virus vaccine was effective at inducing a sero-response and was well tolerated in 2 clinical trials

Published with #IDWeek2023

ACORN RCT: Among hospitalized adults, treatment with piperacillin-tazobactam did not increase incidence of AKI or death.

Treatment with cefepime resulted in more neurological dysfunction.

Tap link for full trial results.

ja.ma/3RYQHSD

Contact your congressional representatives and urge them to reauthorize PEPFAR: idsociety.org/PEPFAR

Ready for #bugbowl IDSA IDWeek

Today I became the first Black PharmD to receive an award from the IDSA . Thank you God. Thank you to the Pastors of C.O.P.E. and IECAAC for allowing me into your sanctuaries and trusting me with your communities. #pushingforward

I have a VERY IMPORTANT announcement

#IDWeek2023 has PUPPIES!!!!!

Check out my poster (771)!

Come visit me! 🥰 The Puppy Wellness Zone is open in the Exhibit Hall now until 2pm ET.